Sol-Gel Technologies (SLGL) Short-term Investments (2018 - 2024)
Sol-Gel Technologies (SLGL) reported Short-term Investments of $12000.0 for Q4 2024, down 99.94% year-over-year from $20.5 million in Q1 2024, and down 99.8% quarter-over-quarter from $6.0 million in Q2 2024.
Sol-Gel Technologies (SLGL) Short-term Investments (2018 - 2024) Analysis & Trends
Sol-Gel Technologies (SLGL) has 7 years of Short-term Investments data on file, last reported at $12000.0 in Q4 2024.
- Short-term Investments for Q4 2024 came in at $12000.0, down 99.94% year-over-year; the trailing twelve-month figure through Dec 2024 was $12000.0 (down 99.94% YoY), and the FY2024 annual result was $12000.0, down 99.94% from the prior year.
- Short-term Investments eased to $12000.0 in Q4 2024 per SLGL's latest filing, from $6.0 million in the prior quarter.
- Over five years, Short-term Investments peaked at $21.7 million in Q4 2020 and troughed at -$19.9 million in Q2 2020.
- A 5-year average of $3.9 million and a median of $1.1 million in 2021 frame the typical range for Short-term Investments.
- The sharpest annual moves came in 2020 and 2024: Short-term Investments plunged 2090.0% in 2020, then soared 700.0% in 2024.
- A 5-year view of Short-term Investments shows it stood at $21.7 million in 2020, then sank by 92.11% to $1.7 million in 2021, then jumped by 407.78% to $8.7 million in 2022, then surged by 135.9% to $20.5 million in 2023, then plunged by 99.94% to $12000.0 in 2024.
- Business Quant data shows SLGL's Short-term Investments at $12000.0 in Q4 2024, $6.0 million in Q2 2024, and $20.5 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Sol-Gel Technologies | 207.80 Mn | 197.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 12,000.00 |
| Jun 30, 2024 | 6.00 Mn |
| Dec 31, 2023 | 20.47 Mn |
| Jun 30, 2023 | -1.00 Mn |
| Dec 31, 2022 | 8.68 Mn |
| Jun 30, 2022 | 448,000.00 |
| Dec 31, 2021 | 1.71 Mn |
| Jun 30, 2021 | 500,000.00 |
| Dec 31, 2020 | 21.65 Mn |
| Jun 30, 2020 | -19.90 Mn |
| Dec 31, 2019 | 40.97 Mn |
| Jun 30, 2019 | 1.00 Mn |
| Dec 31, 2018 | 56.66 Mn |
| Jun 30, 2018 | 3.00 Mn |